The log reductions from the day 0 values are provided in the table below.
Challenge Organism
Escherichia coli (ATCC 8739)
Pseudomonas aeruginosa (ATCC 09027)
Staphylococcus aureus (ATCC 6538)
Klebsiella pneumonia (ATCC 4352)
Candida albicans (ATCC 10231)
Aspergillus niger (ATCC 16404)
PREVENA™ INCISION MANAGEMENT SYSTEM SITE PREPARATION
1.
Prior to surgery, shave or clip the surgical area where the dressing will be applied to
improve dressing adhesion and seal integrity.
2.
Gather all items needed for application:
sterile wound cleaning solution, e.g. water, saline or alcohol
•
sterile gauze or other material to clean application site
•
all components of the PREVENA™ Therapy System (dressing and therapy unit)
•
3.
After surgery, cleanse the application site with sterile gauze and sterile wound cleaning
solution using a circular motion beginning at the center of the surgical area and extending
outward to ensure that the site is free of foreign material.
4.
Pat the application site dry with sterile gauze. To ensure proper adhesion, the application
site must be completely dry before dressing is applied.
DRAIN TUBES AND PAIN MANAGEMENT CONTROL DEVICES
The PREVENA™ Therapy System can be used with both drain tubes and pain devices, provided
the dressing is not placed over tubing where it exits the skin. Surgical drains must be routed
under the skin beyond the boundary of the dressing and function independently of the
PREVENA™ Therapy System.
NOTE: While the concomitant use of surgical drains is allowable with the PREVENA™ Therapy
System, the system must not be used as an outlet or reservoir for the drain.
Mean Log Reduction from Day 0
Day 1
Day 3
2.2
4.0
2.0
3.9
1.6
3.6
1.4
1.8
2.5
3.1
2.2
4.1
9
Day 5
Day 7
3.9
4.5
3.5
3.7
3.6
3.5
2.7
3.5
3.2
3.2
4.0
3.6